Evaluation of somatic and/or germline mosaicism in congenital malformation of the eye.

Autor: Chesneau B; Service de Génétique Médicale, Hôpital Purpan, CHU de Toulouse, Toulouse, France.; Centre de Référence pour les Affections Rares en Génétique Ophtalmologique (CARGO), CHU de Toulouse, Toulouse, France., Ivashchenko V; Service de Génétique Médicale, Hôpital Purpan, CHU de Toulouse, Toulouse, France., Habib C; Service de Génétique Médicale, Hôpital Purpan, CHU de Toulouse, Toulouse, France., Gaston V; Service de Génétique Médicale, Hôpital Purpan, CHU de Toulouse, Toulouse, France., Escudié F; Département d'anatomopathologie, IUCT Oncopole, Toulouse, France., Morel G; Service de Génétique Médicale, CHU de Rennes, Rennes, France., Capri Y; Service de Génétique Médicale, Hôpital Robert Debré, APHP, Paris, France., Vincent-Delorme C; Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHRU de Lille, Lille, France., Calvas P; Service de Génétique Médicale, Hôpital Purpan, CHU de Toulouse, Toulouse, France.; Centre de Référence pour les Affections Rares en Génétique Ophtalmologique (CARGO), CHU de Toulouse, Toulouse, France., Chassaing N; Service de Génétique Médicale, Hôpital Purpan, CHU de Toulouse, Toulouse, France.; Centre de Référence pour les Affections Rares en Génétique Ophtalmologique (CARGO), CHU de Toulouse, Toulouse, France., Plaisancié J; Service de Génétique Médicale, Hôpital Purpan, CHU de Toulouse, Toulouse, France. plaisancie.j@chu-toulouse.fr.; Centre de Référence pour les Affections Rares en Génétique Ophtalmologique (CARGO), CHU de Toulouse, Toulouse, France. plaisancie.j@chu-toulouse.fr.; INSERM U1214, ToNIC, Université Toulouse III, Toulouse, France. plaisancie.j@chu-toulouse.fr.
Jazyk: angličtina
Zdroj: European journal of human genetics : EJHG [Eur J Hum Genet] 2023 May; Vol. 31 (5), pp. 526-530. Date of Electronic Publication: 2022 Nov 21.
DOI: 10.1038/s41431-022-01234-3
Abstrakt: Microphthalmia, Anophthalmia and Coloboma (MAC) form a spectrum of congenital eye malformations responsible for severe visual impairment. Despite the exploration of hundreds of genes by High-Throughput Sequencing (HTS), most of the patients remain without genetic diagnosis. One explanation could be the not yet demonstrated involvement of somatic mosaicism (undetected by conventional analysis pipelines) in those patients. Furthermore, the proportion of parental germline mosaicism in presumed de novo variations is still unknown in ocular malformations. Thus, using dedicated bioinformatics pipeline designed to detect mosaic variants, we reanalysed the sequencing data obtained from a 119 ocular development genes panel performed on blood samples of 78 probands with sporadic MAC without genetic diagnosis. Using the same HTS strategy, we sequenced 80 asymptomatic parents of 41 probands carrying a disease-causing variant in an ocular development gene considered de novo after Sanger sequencing of both parents. Reanalysis of the previously sequencing data did not find any mosaic variant in probands without genetic diagnosis. However, HTS of parents revealed undetected SOX2 and PAX6 mosaic variants in two parents. Finally, this work, performed on two large cohorts of patients with MAC spectrum, provides for the first time an overview of the interest of looking for mosaicism in ocular development disorders. Somatic mosaicism does not appear to be frequent in MAC spectrum and might explain only few diagnoses. Thus, other approaches such as whole genome sequencing should be considered in those patients. Parental mosaicism is however not that rare (around 5%) and challenging for genetic counselling.
(© 2022. The Author(s), under exclusive licence to European Society of Human Genetics.)
Databáze: MEDLINE
Externí odkaz: